Gene transfer to induce angiogenesis in myocardial and limb ischaemia

Bibliography

• BUDOFF MJ: Electron beam computed tomography: calcification and lipid lowering interventions. Z Kardiel. (2000) 89:130–134.
   PubMedGoogle Scholar
• BUSCH T, SIRBU H, ALEKSIC I, FRIEDRICH M, DALICHAU H: Importance of cardiovascular interventions before surgery for abdominal aortic aneurysms. Cardievasc. Surg. (2000) 8:18–21.
   PubMedGoogle Scholar
• MOONEY A: Treating patients with hypertriglyceridaemia saves lives: triglyceride revisited. Curr. Med. Res. Opin. (1999) 15:65–77.
   PubMed Web of Science ®Google Scholar
• TAVAZZI L: Clinical epidemiology of acutemyocardial infarction. Am. Heart j. (1999) 138:48–54.
   Google Scholar
• YUTANI C, IMAKITA M, ISHIBASHI- UEDA H, TSUKAMOTO Y, NISHIDA N, IKEDA Y: Coronary atherosclerosis and interventions: pathological sequences and restenosis. Patna kir (1999) 49:273–290.
   Google Scholar
• MCPHERSON R: Controversies in primaryprevention among hyperlipidemic patients. Cart. J. Cardin]. (1999) 15(Suppl. B):16B–19B.
   Google Scholar
• KILARU PK, KELLY RF, CALVIN JE, PARRILLO JE: Utilization of coronary angiography and revascularization after acute myocardial infarction in men and women risk stratified by the American College of Cardiology/American Heart Association guidelines. j Am. Coll. CardioL (2000) 35:974–979.
   PubMed Web of Science ®Google Scholar
• EAGLE KA, GUYTON RA, DAVIDOFF R et al.: ACC/AHA Guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1991 guidelines for coronary artery bypass graft surgery). American College of Cardiology/ American Heart Association. j Am. Coll. CardioL (1999) 34:1262–1347.
   PubMed Web of Science ®Google Scholar
• JONES EL, CRAVER JM, GUYTON RA et al.: Importance of complete revascularization in performance of the coronary bypass operation. Am. j CardioL (1983) 51:7–12.
   PubMed Web of Science ®Google Scholar
• MCNEER JF, CONLEY MJ, STARMER CF et al.: Complete and incomplete revascularization at aortocoronary bypass surgery: experience with 392 consecutive patients. kn. Heart J. (1974) 88:176–182.
   PubMed Web of Science ®Google Scholar
• BAUTERS C: Growth factors as a potential new treatment for ischemic heart disease. CardioL (1997) 20:11 52–7.
   Web of Science ®Google Scholar
• FOLKMAN J: Angiogenic therapy of the human heart. Circulation (1998) 97:628–629.
   PubMed Web of Science ®Google Scholar
• FRAZIER OH, KADIPASAOGLU KA, COOLEY DA: Transmyocardial laser revascularization. Does it have a role in the treatment of ischemic heart disease? Tex. Heart. Inst. j (1998) 25:24–29.
   Google Scholar
• HUSSAIN FM, HEILBRON M Jr.: A review of the literature: transmyocardial laser revascularization. j Chia. Laser Med. Surg. (1997) 15:57–63.
   Google Scholar
• SELLKE FW, LAHAM RJ, EDELMAN ER, PEARLMAN JD, SIMONS M: Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann. Thorac. Surg. (1998) 65:1540–1544.
   PubMed Web of Science ®Google Scholar
• JACKSON MR, CLAGETT GP: Antithrombotic therapy in peripheral arterial occlusive disease. Chest (2001) 119:283S–299S.
   Google Scholar
• KING SB 3rd, MEIER B: Interventional treatment of coronary heart disease and peripheral vascular disease. Circulation (2000) 102:IV 81–86.
   Google Scholar
• STRANDNESS DE Jr., EIDT JF: Peripheral vascular disease. Circulation (2000) 102:IV 46–51.
   Google Scholar
• LAHAM RJ, SIMONS M: Growth factor therapy in ischemic heart disease. In: Angiogerresis in Health and Disease. Rubanyi G (Ed.), Marcel Decker, New York (2000):451–475.
   Google Scholar
• WARE JA, SIMONS M: Angiogenesis in ischemic heart disease. Nature Med. (1997) 3:158–164.
   PubMed Web of Science ®Google Scholar
• SCHAPER W, ITO W: Molecular mechanisms of collateral vessel growth. Circ. Res. (1996) 79:911–919.
   PubMed Web of Science ®Google Scholar
• JUILLIERE Y, MARIE PY, DANCHIN N, KARCHER G, BERTRAND A, CHERRIER F: Evolution of myocardial ischemia and left ventricular function in patients with angina pectoris without myocardial infarction and total occlusion of the left anterior descending coronary artery and collaterals from other coronary arteries. Am. J. CardioL (1991) 68:7–12.
   PubMed Web of Science ®Google Scholar
• NISHIGAMI K, ANDO M, HAYASAKI K: Effects of antecedent anginal episodes and coronary artery stenosis on left ventricular function during coronary occlusion. Ain. Heart j (1995) 130:244–247.
   PubMed Web of Science ®Google Scholar
• SASAYAMA S, FUJITA M: Recent insightsinto coronary collateral circulation. Circulation (1992) 85:1197–1204.
   PubMed Web of Science ®Google Scholar
• STONE DA, CORRETTI MC, HAWKE MW HERZOG W RODRIGUEZ S, PLOTNICK GD: The influence of angiographically demonstrated coronary collaterals on the results of stress echocardiography. Clin CardioL (1995) 18:205–208.
   PubMed Web of Science ®Google Scholar
• LAHAM R, REZAEE M, POST M et al.:Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. j PharmacoL Exp. Ther. (2000) 292:795–802.
   PubMed Web of Science ®Google Scholar
• SIMONS M, LAHAM RJ: Therapeutic angiogenesis in myocardial ischemia. In: Angiogerresis and cardiovascular disease. Ware J, Simons M (Eds.) Oxford University Press, New York (1999):289–320.
   Google Scholar
• ISNER JM, WALSH K, SYMES J et al.: Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease [news]. Circulation (1995) 91:2687–2692.
   PubMed Web of Science ®Google Scholar
• ISNER JM, PIECZEK A, SCHAINFELDR et al.: Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in a patient with ischaemic limb. Lancet (1996) 348:370–374.
   PubMed Web of Science ®Google Scholar
• MACK CA, PATEL SR, SCHWARZ EA et al.: Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. j Thome. Cardiovasc. Surg. (1998) 115:168-176. Discussion 176–177.
   Google Scholar
• MAGOVERN CJ, MACK CA, ZHANG J et al.: Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Ann. Thome. Surg. (1996) 62:425-33. Discussion 433–434.
   Google Scholar
• GIORDANO FJ, PING P, MCKIRNAN MD et al.: Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. (1996) 2:534–539.
   PubMed Web of Science ®Google Scholar
• MUHLHAUSER J, PILI R, MERRILL MJ et al.: In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor. Hum. Gene. Ther. (1995) 6:1457–1465.
   PubMed Web of Science ®Google Scholar
• LAHAM R, SELLKE F, EDELMAN E et al.: Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a Phase I randomized, double-blind, placebo-controlled trial. Circulation (1999) 100:1865–1871.
   PubMed Web of Science ®Google Scholar
• LAHAM RJ, REZAEE M, POST M et al.: Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution. Drug Metab. Dispos. (1999)27:821–826.
   PubMed Web of Science ®Google Scholar
• LI J, POST M, VOLK R et al.: PR39, a peptide regulator of angiogenesis. Nature Med. (2000) 6:49–55.
   PubMed Web of Science ®Google Scholar
• IYER NV, KOTCH LE, AGANI F et al: Cellular and developmental control of 02 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. (1998) 12:149–162.
   PubMed Web of Science ®Google Scholar
• KOTCH LE, IYER NV, LAUGHNER E, SEMENZA GL: Defective vascularization of HIF-lalpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev. Biol. (1999) 209:254–267.
   PubMed Web of Science ®Google Scholar
• YU AY, SHIMODA LA, IYER NV et al.: Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. Invest. (1999) 103:691–696.
   Google Scholar
• PHILLIPS MI: Somatic gene therapy for hypertension. Braz. j. Med. Biol. Res. (2000) 33:715–721.
   PubMed Web of Science ®Google Scholar
• MACCOLL GS, NOVO FJ, MARSHALL NJ, WATERS M, GOLDSPINK G, BOULOUX PM: Optimisation of growth hormone production by muscle cells using plasmid DNA. j. Endocrinol. (2000) 165:329–336.
   PubMed Web of Science ®Google Scholar
• NISHIKAWA M, YAMAUCHI M, MORIMOTO K, ISHIDA E, TAKAKURA Y, HASHIDA M: Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Ther. (2000) 7:548–555.
   PubMed Web of Science ®Google Scholar
• SHANGGUAN T, CABRAL-LILLY D, PURANDARE U et al.: A novel N-acyl phosphatidylethanolamine-containing delivery vehicle for spermine-condensed plasmid DNA. Gene Ther. (2000) 7:769–783.
   PubMed Web of Science ®Google Scholar
• ATIENZA C JR., ELLIOTT MJ, DONG YB et al.: Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors. Intl Mol. Med. (2000) 6:55–63.
   Google Scholar
• BILBAO R, GEROLAMI R, BRALET MP et al.: Transduction efficacy, antitumoral effect, and toxicity of adenovirus- mediated herpes simplex virus thymidine kinasei ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model. Cancer Gene Ther. (2000) 7:657–662.
   PubMed Web of Science ®Google Scholar
• CHEN E KOVESDI I, BRUDER JT: Effective repeat administration with adenovirus vectors to the muscle. Gene Ther. (2000) 7:587–595.
   PubMed Web of Science ®Google Scholar
• LEE EJ, THIMMAPAYA B, JAMESON JL: Stereotactic injection of adenoviral vectors that target gene expression to specific pituitary cell types: implications for gene therapy. Neurosurgery (2000) 46:1461-1468. Discussion 1468–1469.
   Google Scholar
• SMITH E SHULER FD, GEORGESCU HI et al.: Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin- I. Arthritis Rheum. (2000) 43:1156–1164.
   Google Scholar
• WALTER G, BARTON ER, SWEENEY HL: Non-invasive measurement of gene expression in skeletal muscle. Proc. Natl. Acad. Sci. USA (2000) 97:5151–5155.
   PubMed Web of Science ®Google Scholar
• KUMAR-SINGH R, YAMASHITA CK, TRAN K, FARBER DB: Construction of encapsidated (gutted) adenovirus minichromosomes and their application to rescue of photoreceptor degeneration. Methods Enzymol. (2000) 316:724–743.
   PubMed Web of Science ®Google Scholar
• HARTIGAN O CONNOR D, CHAMBERLAIN JS: Developments in gene therapy for muscular dystrophy. Microsc. Res. Tech. (2000) 48:223–238.
   PubMed Web of Science ®Google Scholar
• HARTIGAN O CONNOR D, AMALFITANO A, CHAMBERLAIN JS: Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase. I Viral. (1999) 73:7835–7841.
   Google Scholar
• DUTHEIL N, SHI F, DUPRESSOIR T, LINDEN RIVI: Adeno-associated virus site-specifically integrates into a muscle- specific DNA region. Proc. Natl. Acad. Sci. USA (2000) 97:4862–4866.
   PubMed Web of Science ®Google Scholar
• DRITTANTI L, RIVET C, MANCEAU P, DANOS 0, VEGA M: High throughput production, screening and analysis of adeno-associated viral vectors. Gene Ther. (2000) 7:924–929.
   PubMed Web of Science ®Google Scholar
• HUDDE T, RAYNER SA, DE ALWIS Metal.: Adeno-associated and herpes simplex viruses as vectors for gene transfer to the corneal endothelium. Cornea (2000) 19:369–373.
   Google Scholar
• DEBELAK D, FISHER J, IULIANO S, SESHOLTZ D, SLOANE DL, ATKINSON EM: Cation-exchange high-performance liquid chromatography of recombinant adeno-associated virus Type 2. Chromatogr. B. Biomed. Sci. Appl. (2000) 740:195–202.
   PubMedGoogle Scholar
• SUN L, LI J, XIAO X: Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nature Med. (2000) 6:599–602.
   PubMed Web of Science ®Google Scholar
• DUAN D, YUE Y, YAN Z, ENGELHARDT JF: A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nature Med. (2000) 6:595–598.
   PubMed Web of Science ®Google Scholar
• NAKAI H, STORM TA, KAY MA: Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat. Biotechnol. (2000) 18:527–532.
   PubMed Web of Science ®Google Scholar
• RUDICH SM, ZHOU S, SRI VASTAVA R, ESCOBEDO JA, PEREZ RV, MANNING WC: Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoietin in monkeys.j Surg. Res. (2000) 90:102–108.
   PubMed Web of Science ®Google Scholar
• BOHL D, BOSCH A, CARDONA A, SALVETTI A, HEARD JM: Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle. Blood (2000) 95:2793–2798.
   PubMed Web of Science ®Google Scholar
• HIRATA RK, RUSSELL DW: Design and packaging of adeno-associated virus gene targeting vectors. I Viral. (2000) 74:4612–4620.
   Google Scholar
• COSTELLO E, MUNOZ M, BUETTI E, MEYLAN PR, DIGGELMANN H, THALI M: Gene transfer into stimulated and unstimulated T lymphocytes by HIV- 1-derived lentiviral vectors. Gene Ther. (2000) 7:596–604.
   PubMed Web of Science ®Google Scholar
• NG YY, VEENHUIZEN P, LOKHORST H, STAAL FJ: Frape-1 and Frape-3: two different recombinant retroviruses encoding the same human marker gene. Cancer Gene Ther. (2000) 7:624–628.
   PubMed Web of Science ®Google Scholar
• PALU G, PAROLIN C, TAKEUCHI Y, PIZZATO M: Progress with retroviral gene vectors. Rev Med. Virol. (2000) 10:185–202.
   PubMed Web of Science ®Google Scholar
• PARVEEN Z, KRUPETSKY A, ENGELSTADTER M, CICHUTEK K, POMERANTZ RJ, DORNBURG R: Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells. Nat. Biotechnol. (2000) 18:623–629.
   PubMed Web of Science ®Google Scholar
• SOLAIMAN F, ZINK MA, XU G et al.: Modular retro-vectors for transgenic and therapeutic use. Mol. Reprod. Dev. (2000) 56:309–315.
   PubMed Web of Science ®Google Scholar
• MARSHALL E: Improving gene therapy'stool kit. Science (2000) 288:953.
   PubMedGoogle Scholar
• FOLLENZI A, AILLES LE, BAKOVIC S, GEUNA M, NALDINI L: Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. (2000) 25:217–222.
   PubMed Web of Science ®Google Scholar
• JOHNSON LG, OLSEN JC, NALDINI L, BOUCHER RC: Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo. Gene Ther. (2000) 7:568–574.
   PubMed Web of Science ®Google Scholar
• CIOFFI L, STURTZ FG, WITTMER S etal.: A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein E. Gene Ther. (1999) 6:1153–1159.
   Google Scholar
• POWELL C, SHANSKY J, DEL TATTO M et al.: Tissue-engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy. Hum. 993 Gene Ther. (1999) 2:565–77.
   Google Scholar
• RINSCH C, REGULIER E, DEGLON N,DALLE B, BEUZARD Y, AEBISCHER P: A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum. Gene Ther. (1997) 8:1881–1889.
   PubMed Web of Science ®Google Scholar
• SU L, LEER, BONYHADI M et al: Hematopoietic stem cell-based gene therapy for acquired immunodeficiency syndrome: efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro. Blood (1997) 89:2283–2290.
   PubMed Web of Science ®Google Scholar
• ZHANG J, RUSSELL SJ: Vectors for cancer gene therapy. Cancer Metastasis Rev (1996) 15:385–401.
   PubMed Web of Science ®Google Scholar
• NAM M, JOHNSTON P, LAL B, INDURTI R, WILSON MA, LATERRA J: Endothelial cell-based cytokine gene delivery inhibits 9L glioma growth in vivo. Brain Res. (1996) 731:161–170.
   PubMed Web of Science ®Google Scholar
• WEI Y, QUERTERMOUS T, WAGNER TE : Directed endothelial differentiation of cultured embryonic yolk sac cells in vivo provides a novel cell-based system for gene therapy. Stem Cells (1995) 13:541–547.
   PubMed Web of Science ®Google Scholar
• NAGY JA, SHOCKLEY TR, MASSE EM, HARVEY VS, HOFF CM, JACKMAN RW: Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface. Gene Ther. (1995) 2:402–410.
   PubMed Web of Science ®Google Scholar
• ROSENTHAL FM, FRUH R, HENSCHLER R etal.: Cytokine therapy with gene-transfected cells: single injection of irradiated granulocyte-macrophage colony-stimulating factor-transduced cells accelerates hematopoietic recovery after cytotoxic chemotherapy in mice. Blood (1994) 84:2960–2965.
   Google Scholar
• TOMITA S, LI RK, WEISEL RD etal.: Autologous transplantation of bone marrow cells improves damaged heart function. Circulation (1999) 100:II 247–256.
   Google Scholar
• KOBAYASHI T, HAMANO K, LI TS et al.: Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. I Surg. Res. (2000) 89:189–195.
   PubMed Web of Science ®Google Scholar
• ABRAHAM NG, JIANG S, YANG L et al: Adenoviral vector-mediated transfer of human heme oxygenase in rats decreases renal heme-dependent arachidonic acid epoxygenase activity. j Pharmacol Esp. Ther. (2000) 293:494–500.
   PubMed Web of Science ®Google Scholar
• IWATATE M, MIURA T, IKEDA Y et al:Effects of in vivo gene transfer of fibroblast growth factor-2 on cardiac function and collateral vessel formation in the microembolized rabbit heart. jun. Circ. (2001) 65:226–231.
   PubMed Web of Science ®Google Scholar
• MIAO W, LUO Z, KITSIS RN, WALSH K: Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo. J. Mol. Cell Cardiol (2000) 32:2397–2402.
   PubMed Web of Science ®Google Scholar
• LAI NC, ROTH DM, GAO MH et al:Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity. Circulation (2000) 102:2396–2401.
   PubMed Web of Science ®Google Scholar
• ROSENGART TK, LEE LY, PATEL SR et al.: Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation (1999) 100:468–474.
   PubMed Web of Science ®Google Scholar
• SYMES JF, LOSORDO DW, VALE PR et al.: Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann. Thorac. Surg. (1999) 68:830-836. Discussion 836–837.
   Google Scholar
• FRENCH BA, MAZUR W, GESKE RS, BOLLI R: Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation (1994) 90:2414–2424.
   PubMed Web of Science ®Google Scholar
• MUHLHAUSER J, JONES M, YAMADA I et al.: Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther. (1996) 3:145–153.
   PubMed Web of Science ®Google Scholar
• MUHLHAUSER J, MERRILL MJ, PILI R etal.: VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ. Res. (1995) 77:1077–1086.
   Google Scholar
• LOSORDO DW, VALE PR, SYMES JF et al.: Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation (1998) 98:2800–2804.
   PubMed Web of Science ®Google Scholar
• TAKESHITA S, WEIR L, CHEN D et al: Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochern. Biophys. Res. Commun. (1996) 227:628–635.
   PubMed Web of Science ®Google Scholar
• TABATA H, SILVER M, ISNER JM: Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA. Cardiovasc. Res. (1997) 35:470–479.
   PubMed Web of Science ®Google Scholar
• WITZENBICHLER B, ASAHARA T, MUROHARA T et al: Vascular endothelial growth factor-C (VEGF-CNEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am. j Pathol (1998) 153:381–394.
   PubMed Web of Science ®Google Scholar
• VINCENT KA, SHYU KG, LUO Y et al:Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-lalpha/VP16 hybrid transcription factor. Circulation (2000) 102:2255–2261.
   PubMed Web of Science ®Google Scholar
• BAUMGARTNER I, PIECZEK A, MANOR 0 et al: Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation (1998) 97:1114–1123.
   PubMed Web of Science ®Google Scholar
• BAUMGARTNER I, RAUH G, PIECZEK A et al.: Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann. Intern. Med. (2000) 132:880-884. Affiliation
   Google Scholar